Cargando…
Interleukin-17-dependent CXCL-13 mediates mucosal vaccine-induced immunity against tuberculosis
The variable efficacy of tuberculosis (TB) vaccines and the emergence of drug resistant strains of Mycobacterium tuberculosis (Mtb) emphasize the urgency for not only generating new and more effective vaccines against TB, but also understanding the underlying mechanisms that mediate vaccine-induced...
Autores principales: | Gopal, Radha, Rangel-Moreno, Javier, Slight, Samantha, Lin, Yinyao, Nawar, Hesham F., Fallert Junecko, Beth A., Reinhart, Todd A., Kolls, Jay, Randall, Troy D., Connell, Terry D., Khader, Shabaana A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732523/ https://www.ncbi.nlm.nih.gov/pubmed/23299616 http://dx.doi.org/10.1038/mi.2012.135 |
Ejemplares similares
-
Lipocalin 2 Regulates Inflammation during Pulmonary Mycobacterial Infections
por: Guglani, Lokesh, et al.
Publicado: (2012) -
Unexpected Role for IL-17 in Protective Immunity against Hypervirulent Mycobacterium tuberculosis HN878 Infection
por: Gopal, Radha, et al.
Publicado: (2014) -
Profiling Early Lung Immune Responses in the Mouse Model of Tuberculosis
por: Kang, Dongwan D., et al.
Publicado: (2011) -
Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection
por: Treerat, Puthayalai, et al.
Publicado: (2017) -
Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy
por: Griffiths, Kristin L., et al.
Publicado: (2016)